phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
Published 1 year ago • 208 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
3:31
phe885, a novel bcma-directed car-t therapy for patients with r/r multiple myeloma
-
5:11
phase i study of phe885 car t-cell therapy in r/r multiple myeloma
-
1:27
early results of phe885, a novel bcma-directed car-t therapy for the treatment of r/r mm
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
40:33
open mics with dr. stites: “miraculous” new treatment for multiple myeloma
-
31:15
multiple myeloma in 2023: what patients & caregivers need to know now! | the patient story
-
23:37
after 4 treatments, my cancer kept coming back | julie's multiple myeloma story | the patient story
-
3:00
fhvh-bcma-t car t-cell therapy shows efficacy in r/r myeloma
-
1:24
improving manufacturing of car-t cells in multiple myeloma: phe885 & other novel constructs
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
0:45
car t-cell therapy in lenalidomide-refractory multiple myeloma
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
2:55
phe885 car-t cell therapy shows high response rates for r/r multiple myeloma in phase 1
-
2:37
car-t cells for myeloma: experience from china
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
5:46
where in the treatment sequence should car t-cells be used for myeloma?
-
1:02
bcma-specific car-t cells for r/r multiple myeloma
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:53
the future of multiple myeloma treatment